| 0006-4305 | Renflexis | Non-Proprietary Name: Infliximab | Injection, Powder, Lyophilized, For Solution | Intravenous | Merck Sharp & Dohme Llc | ACTIVE |
| 0069-0809 | Inflectra | Non-Proprietary Name: Infliximab-dyyb | Injection, Powder, Lyophilized, For Solution | Intravenous | Pfizer Laboratories Div Pfizer Inc | ACTIVE |
| 50090-6411 | Amjevita | Non-Proprietary Name: Adalimumab-atto | Injection | Subcutaneous | A-s Medication Solutions | ACTIVE |
| 50090-6428 | Amjevita | Non-Proprietary Name: Adalimumab-atto | Injection | Subcutaneous | A-s Medication Solutions | ACTIVE |
| 50474-710 | Cimzia | Non-Proprietary Name: Certolizumab Pegol | Injection, Solution | Subcutaneous | Ucb, Inc. | ACTIVE |
| 55513-399 | Amjevita | Non-Proprietary Name: Adalimumab-atto | Injection | Subcutaneous | Amgen Inc | ACTIVE |
| 55513-400 | Amjevita | Non-Proprietary Name: Adalimumab-atto | Injection | Subcutaneous | Amgen Inc | ACTIVE |
| 55513-410 | Amjevita | Non-Proprietary Name: Adalimumab-atto | Injection | Subcutaneous | Amgen Inc | ACTIVE |
| 55513-411 | Amjevita | Non-Proprietary Name: Adalimumab-atto | Injection | Subcutaneous | Amgen Inc | ACTIVE |
| 55513-413 | Amjevita | Non-Proprietary Name: Adalimumab-atto | Injection | Subcutaneous | Amgen Inc | ACTIVE |
| 55513-479 | Amjevita | Non-Proprietary Name: Adalimumab-atto | Injection | Subcutaneous | Amgen Inc | ACTIVE |
| 55513-480 | Amjevita | Non-Proprietary Name: Adalimumab-atto | Injection | Subcutaneous | Amgen Inc | ACTIVE |
| 55513-481 | Amjevita | Non-Proprietary Name: Adalimumab-atto | Injection | Subcutaneous | Amgen Inc | ACTIVE |
| 55513-482 | Amjevita | Non-Proprietary Name: Adalimumab-atto | Injection | Subcutaneous | Amgen Inc | ACTIVE |
| 55513-670 | Avsola | Non-Proprietary Name: Infliximab-axxq | Injection, Powder, Lyophilized, For Solution | Intravenous | Amgen Inc | ACTIVE |
| 57894-030 | Remicade | Non-Proprietary Name: Infliximab | Injection, Powder, Lyophilized, For Solution | Intravenous | Janssen Biotech, Inc. | ACTIVE |
| 57894-070 | Simponi | Non-Proprietary Name: Golimumab | Injection, Solution | Subcutaneous | Janssen Biotech, Inc. | ACTIVE |
| 57894-071 | Simponi | Non-Proprietary Name: Golimumab | Injection, Solution | Subcutaneous | Janssen Biotech, Inc. | ACTIVE |
| 57894-160 | Infliximab | Non-Proprietary Name: Infliximab | Injection, Powder, Lyophilized, For Solution | Intravenous | Janssen Biotech, Inc. | ACTIVE |
| 57894-350 | Simponi Aria | Non-Proprietary Name: Golimumab | Solution | Intravenous | Janssen Biotech, Inc. | ACTIVE |
| 58406-010 | Enbrel | Non-Proprietary Name: Etanercept | Solution | Subcutaneous | Immunex Corporation | ACTIVE |
| 58406-021 | Enbrel | Non-Proprietary Name: Etanercept | Solution | Subcutaneous | Immunex Corporation | ACTIVE |
| 58406-032 | Enbrel | Non-Proprietary Name: Etanercept | Solution | Subcutaneous | Immunex Corporation | ACTIVE |
| 58406-044 | Enbrel | Non-Proprietary Name: Etanercept | Solution | Subcutaneous | Immunex Corporation | ACTIVE |
| 58406-055 | Enbrel | Non-Proprietary Name: Etanercept | Solution | Subcutaneous | Immunex Corporation | ACTIVE |
| 58406-435 | Enbrel | Non-Proprietary Name: Etanercept | Solution | Subcutaneous | Immunex Corporation | ACTIVE |
| 58406-445 | Enbrel | Non-Proprietary Name: Etanercept | Solution | Subcutaneous | Immunex Corporation | ACTIVE |
| 58406-446 | Enbrel | Non-Proprietary Name: Etanercept | Solution | Subcutaneous | Immunex Corporation | ACTIVE |
| 58406-455 | Enbrel | Non-Proprietary Name: Etanercept | Solution | Subcutaneous | Immunex Corporation | ACTIVE |
| 58406-456 | Enbrel | Non-Proprietary Name: Etanercept | Solution | Subcutaneous | Immunex Corporation | ACTIVE |
| 61314-327 | Adalimumab | Non-Proprietary Name: Adalimumab-adaz | Injection, Solution | Subcutaneous | Sandoz Inc. | ACTIVE |
| 61314-454 | Hyrimoz | Non-Proprietary Name: Adalimumab-adaz | Injection, Solution | Subcutaneous | Sandoz Inc | ACTIVE |
| 61314-473 | Hyrimoz | Non-Proprietary Name: Adalimumab-adaz | Injection, Solution | Subcutaneous | Sandoz Inc | ACTIVE |
| 61314-476 | Hyrimoz | Non-Proprietary Name: Adalimumab-adaz | Injection, Solution | Subcutaneous | Sandoz Inc | ACTIVE |
| 61314-509 | Hyrimoz | Non-Proprietary Name: Adalimumab-adaz | Injection, Solution | Subcutaneous | Sandoz Inc | ACTIVE |
| 65219-554 | Idacio | Non-Proprietary Name: Adalimumab | Injection, Solution | Subcutaneous | Fresenius Kabi Usa, Llc | ACTIVE |
| 65219-556 | Idacio | Non-Proprietary Name: Adalimumab | Injection, Solution | Subcutaneous | Fresenius Kabi Usa, Llc | ACTIVE |
| 70114-210 | Yusimry | Non-Proprietary Name: Adalimumab-aqvh | Injection, Solution | Subcutaneous | Coherus Biosciences Inc | ACTIVE |
| 70114-220 | Yusimry | Non-Proprietary Name: Adalimumab-aqvh | Injection, Solution | Subcutaneous | Coherus Biosciences Inc | ACTIVE |
| 72511-400 | Amjevita | Non-Proprietary Name: Adalimumab-atto | Injection | Subcutaneous | Amgen Usa Inc. | ACTIVE |
| 72606-030 | Yuflyma | Non-Proprietary Name: Adalimumab | Injection | Subcutaneous | Celltrion Usa, Inc. | ACTIVE |
| 78206-162 | Renflexis | Non-Proprietary Name: Infliximab | Injection, Powder, Lyophilized, For Solution | Intravenous | Organon Llc | ACTIVE |
| 78206-183 | Hadlima | Non-Proprietary Name: Adalimumab-bwwd | Solution | Subcutaneous | Organon Llc | ACTIVE |
| 78206-184 | Hadlima | Non-Proprietary Name: Adalimumab-bwwd | Solution | Subcutaneous | Organon Llc | ACTIVE |
| 78206-185 | Hadlima | Non-Proprietary Name: Adalimumab-bwwd | Solution | Subcutaneous | Organon Llc | ACTIVE |
| 78206-186 | Hadlima | Non-Proprietary Name: Adalimumab-bwwd | Solution | Subcutaneous | Organon Llc | ACTIVE |
| 78206-187 | Hadlima | Non-Proprietary Name: Adalimumab-bwwd | Solution | Subcutaneous | Organon Llc | ACTIVE |